Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2010-11-09 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ARCONNAY (72610), Sarthe
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE D'ARCONNAY : revenue, balance sheet and financial ratios
SELARL PHARMACIE D'ARCONNAY is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ARCONNAY (72610),
this company of category PME
shows in 2023 a net income positive of 219 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE D'ARCONNAY (SIREN 528201312)
Indicator
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
218 885 €
247 444 €
212 830 €
165 755 €
156 896 €
122 422 €
59 131 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, SELARL PHARMACIE D'ARCONNAY generates positive net income of 219 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 59 k€ -> 219 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
218 885 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
32.19%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
67.532%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
Debt ratio
185.001
144.288
109.974
102.962
76.074
56.504
32.19
Financial autonomy
31.246
35.648
42.72
44.433
50.372
56.275
67.532
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
32.192023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-10 pts over 3 years
In 2023, the debt ratio of SELARL PHARMACIE D'ARCONNAY (32.19) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
67.53%2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good+13 pts over 3 years
In 2023, the financial autonomy of SELARL PHARMACIE D'ARCONNAY (67.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 330.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
Liquidity ratio
142.207
141.025
173.881
223.306
231.696
257.693
330.046
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
330.052023
2020
2021
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent+7 pts over 3 years
In 2023, the liquidity ratio of SELARL PHARMACIE D'ARCONNAY (330.05) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELARL PHARMACIE D'ARCONNAY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELARL PHARMACIE D'ARCONNAY is estimated at
2 582 728 €
(range 1 570 680€ - 3 630 736€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1570k€2582k€3630k€
2 582 728 €Range: 1 570 680€ - 3 630 736€
NAF 5 année 2023
Valuation method used
Net Income Multiple
218 885 €
×
11.8x
=2 582 728 €
Range: 1 570 681€ - 3 630 736€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE D'ARCONNAY with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE D'ARCONNAY
What is the revenue of SELARL PHARMACIE D'ARCONNAY ?
The revenue of SELARL PHARMACIE D'ARCONNAY is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE D'ARCONNAY profitable?
Yes, SELARL PHARMACIE D'ARCONNAY generated a net profit of 219 k€ in 2023.
Where is the headquarters of SELARL PHARMACIE D'ARCONNAY ?
The headquarters of SELARL PHARMACIE D'ARCONNAY is located in ARCONNAY (72610), in the department Sarthe.
Where to find the tax return of SELARL PHARMACIE D'ARCONNAY ?
The tax return of SELARL PHARMACIE D'ARCONNAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE D'ARCONNAY operate?
SELARL PHARMACIE D'ARCONNAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart